The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Excellent news,
This technology is worth an absolute fortune for the company,
What a great turnaround,,
Exciting times we are at the start of a huge recovery for
This company
Great news they’ve been able to commercialise this new technology platform with great potential for royalties on antibodies developed and sold.
I think we will see an attack of that higher over the next few sessions
Ready for a good recovery as FAB has diversified into so many areas of interest and with huge potential also.
I also like the fact that we’ve move into the veterinary sector where there’s an amazing opportunity to increase revenue massively.
Also to be partners with the NCI is a huge milestone for the company and should bring FAB into the limelight’
Just about to begin here.
Mitchell Ho, Ph.D., Deputy Chief, Laboratory of Molecular Biology and Director of the Antibody Engineering Program, Center for Cancer Research, NCI commented: " NCI will test the OptiMAL (R) platform for the discovery of novel antibodies to cancer targets and also SARS-CoV-2. We have a particular interest in Mammalian Cell Display as a discovery engine and look forward to using this in NCI."
Richard Buick, CSO of Fusion, commented: " The expertise and experience of Dr. Ho and his colleagues make NCI an ideal partner for validation of the Optimal (R) library and mammalian cell display technology. I look forward to the collaboration and working closely with the National Cancer Institute."
Can’t say much. But if what I hearing is true, then it could be a great time to be involved.
You’ve still not given any more on these rumours…
Yep
In’sha Allah
Soon.
Totally agree,
Just have to sit back and wait for the news flow to come through.
Well played, going to see fireworks here soon
Added another 50k,
Make the most of these cheap shares.
Atb
6.5 k left under 4.10 rest NT, little more buying and should close around 4.20,
Anyway - They are clearly looking for stock at the moment, they'll happily give me 4.07p for 50K or 100K but only 4.02 for 200K & no quote for 400K
As for buying I don't have enough free cash in my account to get a gauge on that side of things.
LOTM
Donotpanic
Corporal Jones, you're contradicting yourself, saying people don't buy in rumours when that's what you supposed to do (the old adage is buy the rumour - sell the news) & going on about a seller being about & then posting a couple of minutes later that buying pressure is building & news any day .....
Which is why you'd want to be in ahead of the news not after it.
LOTM
Definitely the volume has picked up a lot just lately,
I’m very confident in this company and after a disappointing 2023, it looks like 2024 is going to be a very lucrative year for the company.
Watch this space.
Good to be in here.
With buying pressure building up next leg up soon, news is due any day
LOTM lot people don’t buy on rumours, attention usually comes when share rises to say 30 percent and on riser board , ones this starts moving this will be over 6p within hours, but seller is still around, once that is gone nothing will stop this from going over 6/7
My goodness sexykiwi59, your about the 3rd person today alone going on about positive rumours & yet the share price dropped a lot yesterday on little volume & today's volume is very low as well when you take out the 3 x 200,000 that are an error of some kind since they all have the same timestamp etc.
So is one person passing on the rumour to another, who just happens to use the LSE chat boards ? because if so many people were hearing good vibes, you'd expect to see a lot more trades going through then has occurred to date.
Instead ThunderBird 1 is sat on the launch pad waiting to hear that "ThunderBirds are Go" for lift off
Good luck with your purchase
LOTM
Have been watching these for a while and from the positive rumours I am hearing have finally bought in today.
Mkcap only 4m , this will move very fast on the next news as so many things going on in the background,
This year will see revenues flying in and so will the sp.
Interesting and very positive investors conference.
https://www.google.com/search?q=proactive+investor+fusion+antibodies+plc&ie=UTF-8&oe=UTF-8&hl=en-gb&client=safari#fpstate=ive&vld=cid:14b5e405,vid:IAvbf90GgvQ,st:0
If you’re hearing good news you should give some detail…
I'm hearing good news on the way also
WOW ,, just been reading of a takeover of alpine immune sciences, by vertex for $4.9 billion for one drug, for kidney disease,expected to make upto 100billion...